JKD - iShares Morningstar Large-Cap ETF

NYSEArca - NYSEArca Delayed Price. Currency in USD
165.88
+0.22 (+0.13%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close165.66
Open165.92
Bid163.88 x 1300
Ask166.92 x 1200
Day's Range165.40 - 166.13
52 Week Range133.55 - 170.86
Volume8,065
Avg. Volume17,669
Net Assets824.43M
NAV165.96
PE Ratio (TTM)N/A
Yield2.02%
YTD Return16.78%
Beta (3Y Monthly)0.94
Expense Ratio (net)0.20%
Inception Date2004-06-28
Trade prices are not sourced from all markets
  • Allergan’s Valuations after Its 1Q18 Earnings
    Market Realist11 months ago

    Allergan’s Valuations after Its 1Q18 Earnings

    The chart below shows Allergan’s (AGN) revenues and earnings per share (or EPS) since 1Q17. For 1Q18, Allergan reported EPS of $3.74 on revenues of ~$3.7 billion, representing 2.8% growth in revenues compared to revenues of ~$3.6 billion during 1Q17.

  • Johnson & Johnson’s Revenues Continued to Rise in 1Q18
    Market Realistlast year

    Johnson & Johnson’s Revenues Continued to Rise in 1Q18

    Johnson & Johnson (JNJ) reported 12.6% growth in its revenues to $20.0 billion during 1Q18 as compared to revenues of $17.8 billion during 1Q17. The company surpassed Wall Street analyst estimates for EPS (earnings per share) and revenues and reported EPS of $2.06 on revenues of $20.0 billion during 1Q18 against estimates for EPS of $2.00 on revenues of $19.4 billion during 1Q17.

  • We're sorry this is all we were able to find about this topic.